Clinical trial
Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS…
NCT00002940 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00002940 |
|---|---|
| Title | Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS |
| Official title | Hydroxyurea Treatment of EBV-Associated Primary CNS Lymphoma in Children and Adults With AIDS |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | hydroxyurea |
| Start date | Oct 1, 1996 |
| Primary completion | Mar 1, 2002 |
| Completion | Mar 1, 2002 |
| First posted | Nov 24, 2003 |
| Last update posted | Oct 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: